Medicalgorithmics Expands in the US with its Fifth New IDTF Client, Accelerating Expansion

Implementing its ongoing strategy, Medicalgorithmics, a medtech company listed on the sWIG80 index, has successfully added nine new clients, including five Independent Diagnostic Testing Facility (IDTF) centers in the USA. The company has completed a contract and started a collaboration with First-Call Medical, marking its fifth new IDTF partner in the USA, specializing in heart disease diagnostics. Using Medicalgorithmics’ AI-powered diagnostic platform, the new partner will analyze EKG signals of patients for arrhythmia and other disorders.

Medicalgorithmics Starts Providing ECG Cardiac Safety Services Using AI in a Clinical Trial for a New Drug

Medicalgorithmics has initiated its involvement in providing cardiac safety services for a pioneering clinical trial of a new medication. The trial, now in the drug dosing phase, utilizes Medicalgorithmics’ advanced AI software and ECG diagnostic devices. This initiative is a part of Project OATD-01, carried out for the Polish company Molecure and managed by Simbec-Orion. This exemplifies a significant expansion for Medicalgorithmics into the domain of cardiac safety in clinical trials.

Medicalgorithmics has a contract with the fourth IDTF in the USA under the new strategy

Medicalgorithmics SA, a medtech company listed in the sWIG80 index, has acquired its fourth client in the American IDTF market – independent diagnostic facilities that serve hospitals and medical offices. The company’s new partner, G Medical, will use a proprietary comprehensive system for arrhythmia diagnostics, which primarily includes software and AI algorithms for EKG signal analytics from various heart monitoring devices offered by the new client.als.

Medicalgorithmics with a New Agreement in the United Arab Emirates

Medicalgorithmics, a medtech listed on the sWIG80 index, is expanding its presence in the Middle East. The company has signed an agreement with Canadian Cardiac Centre to provide a comprehensive system for heart arrhythmia diagnostics for a new cardiology center in the United Arab Emirates. The system will include PocketECG devices and a diagnostic platform PCClient based on artificial intelligence (AI).

Medicalgorithmics Invests in Dynamic Growth in Clinical Research Sector

The rapidly increasing demand from the biopharmaceutical industry for services ensuring the cardiac safety of clinical drug trials represents a strong new trend in the global medical technology market. Medicalgorithmics, a medtech company listed on the sWIG80 index, intends to benefit from this trend by focusing on the development of high-margin services in this area. Last year, the company joined two international research projects and is now close to finalizing additional agreements and plans to collaborate with entities organizing clinical trials.

Medicalgorithmics Deploys AI Algorithm as a Standalone Solution inIDTF in the US

Medicalgorithmics, a medtech company listed on the sWIG80 index, has
started providing services to another customer in the US IDTF market.
This is also its first partner to decide to implement the company’s
proprietary DeepRhythmAI (DRAI) algorithms in its diagnostic center.
DRAI has been integrated with IDTF’s software for heart arrhythmia
diagnostics, and Medicalgorithmics will receive remuneration depending
on the number of ECG tests analyzed by artificial intelligence.

Medicalgorithmics Secures Global Software Distribution Contract with Bittium Biosignals Ltd

Medicalgorithmics, a prominent medtech company listed on the Warsaw stock exchange and part of the sWIG80 index, has finalized a software distribution agreement with Bittium Biosignals Ltd (“Bittium”), a subsidiary of Bittium Corporation, a global provider of secure communication solutions, engineering services, and medical technologies, including devices for diagnosing arrhythmias, listed on the NASDAQ Helsinki. This contract is a direct result of the October 2023 memorandum, which focused on software integration and evaluation, demonstrating the efficacy of Medicalgorithmics’ software in conjunction with Bittium’s devices and its potential for significant collaborative growth and value creation.

Medicalgorithmics Records Its First Revenues from New Contracts in the USA

Medicalgorithmics, a medtech company included in the sWIG80 index, has initiated the monetization of agreements with new clients in the IDTF market in the USA. In the second half of 2023, the company secured three such partners. In January, the first invoices were issued to two of them for equipment deliveries and heart data analysis services utilizing the artificial intelligence (AI) algorithm developed by the Polish company. The commencement of service provision for the third entity is scheduled for March.

Medicalgorithmics Summarizes Third Quarter of 2023 and the First Quarter of Execution of its New Business Strategy

Medicalgorithmics, a MedTech company listed in the sWIG80 index, continues to successfully transform its business model in line with the objectives defined in its new development strategy adapted in June 2023. The company has secured several new, significant business partners, including three global leaders in modern cardiac diagnostics, with the goal of becoming their main provider of diagnostic software based on artificial intelligence algorithms.

Medicalgorithmics Announces Key Partnership in Strategic Expansion of Cardiac Diagnostic Services

Medicalgorithmics, an AI-focused MedTech company listed on the sWIG80 index of the Polish Stock Exchange, announces a significant partnership with a European leader in global cardiac diagnostic services. Medicalgorithmics will provide a comprehensive technology platform for cardiac arrhythmia diagnosis, utilizing its proprietary artificial intelligence (AI) algorithms. This system has already been successfully commercialized in 22 countries, with regulatory clearances enabling entry into over 50 countries.

Your submission was succesfull

Software

Get more information
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

VCAST

Get a free demo
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

DRAI

Get a free demo
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

Our company

About us

Our History

Management Team

Partners

Career

Work with us

Job offers

Recommend an employee

Application form